Literature DB >> 30117142

Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.

J Kimble Frazer1, Kevin J Li1, Paul J Galardy2, Sherrie L Perkins3, Anne Auperin4, James R Anderson5, Ross Pinkerton6, Allen Buxton7, Thomas G Gross8, Jean Michon9, Guy Leverger10, Howard J Weinstein11, Lauren Harrison12, Bruce Shiramizu13, Mathew J Barth14, Stanton C Goldman15, Catherine Patte16, Mitchell S Cairo12,17.   

Abstract

Entities:  

Keywords:  zzm321990central nervous systemzzm321990; B cell non-Hodgkin lymphoma; Burkitt lymphoma; paediatric; rituximab

Year:  2018        PMID： 30117142      PMCID： PMC6588172          DOI： 10.1111/bjh.15520

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study.

Authors:  Anne Jourdain; Anne Auperin; Véronique Minard-Colin; Nathalie Aladjidi; Josef Zsiros; Carole Coze; Virginie Gandemer; Yves Bertrand; Guy Leverger; Christophe Bergeron; Jean Michon; Catherine Patte
Journal:  Haematologica       Date:  2015-02-27       Impact factor: 9.941

2.  Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.

Authors:  Stanton Goldman; Lynette Smith; Paul Galardy; Sherrie L Perkins; John Kimble Frazer; Warren Sanger; James R Anderson; Thomas G Gross; Howard Weinstein; Lauren Harrison; Bruce Shiramizu; Matthew Barth; Mitchell S Cairo
Journal:  Br J Haematol       Date:  2014-07-26       Impact factor: 6.998

3.  Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study.

Authors:  Mitchell S Cairo; Richard Sposto; Mary Gerrard; Anne Auperin; Stanton C Goldman; Lauren Harrison; Ross Pinkerton; Martine Raphael; Keith McCarthy; Sherrie L Perkins; Catherine Patte
Journal:  J Clin Oncol       Date:  2012-01-03       Impact factor: 44.544

4.  Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group.

Authors:  Mitchell Cairo; Anne Auperin; Sherrie L Perkins; Ross Pinkerton; Lauren Harrison; Stanton Goldman; Catherine Patte
Journal:  Br J Haematol       Date:  2018-07-09       Impact factor: 6.998

5.  Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.

Authors:  Mitchell S Cairo; Mary Gerrard; Richard Sposto; Anne Auperin; C Ross Pinkerton; Jean Michon; Claire Weston; Sherrie L Perkins; Martine Raphael; Keith McCarthy; Catherine Patte
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

6.  Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.

Authors:  Catherine Patte; Anne Auperin; Mary Gerrard; Jean Michon; Ross Pinkerton; Richard Sposto; Claire Weston; Martine Raphael; Sherrie L Perkins; Keith McCarthy; Mitchell S Cairo
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

7.  Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.

Authors:  Janina Salzburg; Birgit Burkhardt; Martin Zimmermann; Olga Wachowski; Wilhelm Woessmann; Ilske Oschlies; Wolfram Klapper; Hans-Heinrich Wacker; Wolf-Dieter Ludwig; Felix Niggli; Georg Mann; Helmut Gadner; Hansjoerg Riehm; Martin Schrappe; Alfred Reiter
Journal:  J Clin Oncol       Date:  2007-09-01       Impact factor: 44.544

8.  Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.

Authors:  Mary Gerrard; Mitchell S Cairo; Claire Weston; Anne Auperin; Ross Pinkerton; Anne Lambilliote; Richard Sposto; Keith McCarthy; Marie-José T Lacombe; Sherrie L Perkins; Catherine Patte
Journal:  Br J Haematol       Date:  2008-03-26       Impact factor: 6.998
  8 in total
  6 in total

1.  Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents.

Authors:  Andishe Attarbaschi; Oussama Abla; Leila Ronceray; Shweta Bansil; Simon Bomken; Birgit Burkhardt; Francecso Ceppi; Alan K S Chiang; Hema Dave; Alina Fedorova; Michael Henry; Janez Jazbec; Edita Kabickova; Rishi S Kotecha; Jelena Lazic; Jan Loeffen; Natalia Miakova; Tomoo Osumi; Marta Pillon; Apostolos Pourtsidis; Charlotte Rigaud; Gevorg Tamamyan; Sneha Tandon; Anne Uyttebroeck; Jamie Verdu-Amoros; Wilhelm Woessmann; Grazyna Wrobel; Lisa Giulino-Roth
Journal:  Blood Adv       Date:  2019-12-23

Review 2.  Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives.

Authors:  Mitchell S Cairo; Auke Beishuizen
Journal:  Br J Haematol       Date:  2019-02-06       Impact factor: 6.998

Review 3.  Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective.

Authors:  Irtiza N Sheikh; Amr Elgehiny; Dristhi Ragoonanan; Kris M Mahadeo; Yago Nieto; Sajad Khazal
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

4.  Clinical characteristics and treatment outcomes of children and adolescents with aggressive mature B-cell lymphoma: a single-center analysis.

Authors:  Woojung Jeon; Young Kwon Koh; Sunghan Kang; Hyery Kim; Kyung-Nam Koh; Ho Joon Im
Journal:  Blood Res       Date:  2022-03-31

5.  Sequential different B-cell antigen-targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma.

Authors:  Ying Liu; Biping Deng; Bo Hu; Wenqun Zhang; Qing Zhu; Yang Liu; Shan Wang; Pei Zhang; Ying Yang; Junhan Yang; Qinlong Zheng; Xinjian Yu; Zifen Gao; Chunju Zhou; Wei Han; Jing Yang; Ling Jin; Chunrong Tong; Alex H Chang; Yonghong Zhang
Journal:  Blood Adv       Date:  2022-02-08

6.  Educational Case: Burkitt Lymphoma.

Authors:  Caitlin J Alexander; Laura M Wake
Journal:  Acad Pathol       Date:  2019-11-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.